iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of July 24, 2026, IRMD trades at $94.25 with a market cap of $1.20B and a P/E ratio of 50.88. IRMD moved +1.13% today. Year to date, IRMD is -1.06%; over the trailing twelve months it is +66.94%. Its 52-week range spans $47.48 to $107.90. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest IRMD news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $94.25 |
| Market Cap | $1.20B |
| P/E Ratio | 50.88 |
| EPS | $1.86 |
| Dividend Yield | 0.20% |
| 52-Week High | $107.90 |
| 52-Week Low | $47.48 |
| Volume | 70.81K |
| Avg Volume | 0 |
| Revenue (TTM) | $86.28M |
| Net Income | $23.61M |
| Gross Margin | 76.83% |
IRMD analyst coverage data. Average price target: $0.00.